Boston Scientific is reaping the rewards from the energised PFA market opportunity in atrial fibrillation treatment.

Genetically modified pig kidneys begin trials for 50 U.S. kidney failure patients FDA launches clinical trials for organ ...

The Philippines’ inflation settled at 2.9 percent in January 2025, within the government’s target range of 2 percent to 4 ...

Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...

Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...

Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...

Nova  announced today that it completed the acquisition of Sentronics Metrology GmbH, a privately held company headquartered in Germany. The transaction is valued at approximately $60 million, paid in ...

CHARLOTTE, N.C. - Dentsply Sirona Inc. (NASDAQ:XRAY), a global leader in dental products and technologies, has announced the ...

Prices have likely climbed on a swift move from investors to safety due to Trump tariff threats, rising geopolitical tensions and U.S. government debt, and fear of a potential tech rout that could ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Last-minute phone calls pull the North American neighbours back from the brink of a trade war, but the US is still targeting ...